home · filing · 0001104659-24-001154
8-K filed January 4, 2024, 6:59 PM ET
ticker CTEV
CIK 0001793229
leadership
confidence high
sentiment neutral
materiality 0.75
MultiPlan names Travis Dalton as CEO effective March 1, 2024; Dale White becomes Executive Chair
Claritev Corp
Travis Dalton to succeed Dale White as President and CEO on or around March 1, 2024; Dalton previously GM of Oracle Health.
Dale White to become Executive Chair, succeeding Mark Tabak; White remains an employee and receives a $1.5M severance package.
Dalton receives base salary $825,000, sign-on bonus $500,000, target bonus 125%, and equity grants valued over $13M.
Board size increased from 12 to 13 directors; Dalton appointed as Class I director until 2024 annual meeting.
White will receive executive chair base salary of $487,500 and equity grant of $750,000 in fiscal 2024.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2024-03-01
Successor Travis Dalton
Filed January 4, 2024, 6:59 PM ET
On the Transition Date, Mr. White will remain an employee of the Company and be appointed the Executive Chair of the Board.
Effective 2024-03-01
Successor Dale White
Filed January 4, 2024, 6:59 PM ET
Mark Tabak, the Company’s Non-Executive Chair of the Board, will step down from such role, effective as of the Transition Date.
Effective 2024-03-01
Filed January 4, 2024, 6:59 PM ET
Mr. Dalton will become the Company’s President and Chief Executive Officer succeeding Dale White on or around March 1, 2024.
Appointed
Travis Dalton
Class I Director
Effective 2024-03-01
Filed January 4, 2024, 6:59 PM ET
On the Transition Date, Mr. Dalton will be appointed as a Class I Director of the Board to fill the vacancy created by the Board Size Increase
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Dale White changed role as Executive Chair of the Board at Claritev Corp.
Action transitioned to
Role Executive Chair of the Board
Exact text from the filing
On the Transition Date, Mr. White will remain an employee of the Company and be appointed the Executive Chair of the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Mark Tabak changed role as Non-Executive Chair of the Board at Claritev Corp.
Action stepped down from
Role Non-Executive Chair of the Board
Exact text from the filing
Mark Tabak, the Company’s Non-Executive Chair of the Board, will step down from such role, effective as of the Transition Date.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Travis Dalton was appointed as President and Chief Executive Officer at Claritev Corp.
Action appointed
Role President and Chief Executive Officer
Exact text from the filing
Mr. Dalton will become the Company’s President and Chief Executive Officer succeeding Dale White on or around March 1, 2024.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Travis Dalton was appointed as Class I Director at Claritev Corp.
Action appointed
Role Class I Director
Exact text from the filing
On the Transition Date, Mr. Dalton will be appointed as a Class I Director of the Board to fill the vacancy created by the Board Size Increase
View on SEC.gov
Source: SEC EDGAR
accession 0001104659-24-001154
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.